Rate of MMSE score change in Alzheimer's disease: Influence of education and vascular risk factors

[1]  Frederik Barkhof,et al.  Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. , 2008, Radiology.

[2]  Nick C Fox,et al.  Volumetric MRI and cognitive measures in Alzheimer disease , 2008, Journal of Neurology.

[3]  R. Green,et al.  Vascular factors predict rate of progression in Alzheimer disease , 2007, Neurology.

[4]  A. Drzezga,et al.  Gender differences in brain reserve , 2007, Journal of Neurology.

[5]  T. Manolio,et al.  Education and the cognitive decline associated with MRI-defined brain infarct , 2006, Neurology.

[6]  M. Weiner,et al.  Vascular Disease and Risk Factors, Rate of Progression, and Survival in Alzheimer’s Disease , 2006, Journal of geriatric psychiatry and neurology.

[7]  A Drzezga,et al.  Schooling mediates brain reserve in Alzheimer’s disease: findings of fluoro-deoxy-glucose-positron emission tomography , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  C. DeCarli,et al.  Rate of progression differs in frontotemporal dementia and Alzheimer disease , 2005, Neurology.

[9]  Y. Stern,et al.  Education and rates of cognitive decline in incident Alzheimer’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  David A Bennett,et al.  Sex differences in the clinical manifestations of Alzheimer disease pathology. , 2005, Archives of general psychiatry.

[11]  A. Kertesz.  Long-term donepezil treatment in patients with Alzheimer’s disease , 2004 .

[12]  R S Wilson,et al.  Education and the course of cognitive decline in Alzheimer disease , 2004, Neurology.

[13]  P. Stang,et al.  Hypertension and the Rate of Cognitive Decline in Patients With Dementia of the Alzheimer Type , 2004, Alzheimer disease and associated disorders.

[14]  B. Winblad,et al.  APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging , 2004, Neurology.

[15]  J. Kaye,et al.  Predicting the rate of cognitive decline in aging and early Alzheimer disease , 2004, Neurology.

[16]  C. Caltagirone,et al.  Italian Neurological Society guidelines for the diagnosis of dementia: revision I , 2004, Neurological Sciences.

[17]  D. Bennett,et al.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. , 2004, Archives of neurology.

[18]  Yaakov Stern,et al.  Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects , 2003, NeuroImage.

[19]  J. Schneider,et al.  Education modifies the relation of AD pathology to level of cognitive function in older persons , 2003, Neurology.

[20]  Kristine Yaffe,et al.  Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. , 2003, JAMA.

[21]  J Philip Miller,et al.  Rates of progression in mild cognitive impairment and early Alzheimer’s disease , 2002, Neurology.

[22]  J. Ashford,et al.  Modelling mini mental state examination changes in Alzheimer's disease. , 2000, Statistics in medicine.

[23]  T. del Ser,et al.  An autopsy-verified study of the effect of education on degenerative dementia. , 1999, Brain : a journal of neurology.

[24]  Y. Stern,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[25]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[26]  W. Jagust,et al.  The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons , 1999 .

[27]  V. Hachinski,et al.  Factors affecting the age of onset and rate of progression of Alzheimer’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.

[28]  H. Kraemer,et al.  Neurological and psychiatric predictors of mortality in patients with Alzheimer disease in California. , 1997, Archives of neurology.

[29]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[30]  J. Growdon,et al.  Interrater agreement for diagnosis of Alzheimer's disease , 1994, Neurology.

[31]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[32]  J. Haxby,et al.  Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. , 1992, Journal of clinical and experimental neuropsychology.

[33]  W. Kukull,et al.  The validity of 3 clinical diagnostic criteria for Alzheimer's disease , 1990, Neurology.

[34]  L. Thal,et al.  Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease , 1988, Annals of neurology.

[35]  H. Brownell,et al.  Education provides no protection against Alzheimer's disease , 1985, Neurology.

[36]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[37]  A. Drzezga,et al.  Gender differences in brain reserve : an (18)F-FDG PET study in Alzheimer's disease. , 2007, Journal of neurology.

[38]  Y. Stern,et al.  Alzheimer's disease Education and rates of cognitive decline in incident , 2006 .

[39]  B. Miller,et al.  CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .

[40]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[41]  W. Jagust,et al.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. , 1999, JAMA.

[42]  Bruce Neal,et al.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. , 1999, Journal of hypertension.

[43]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.